All In Biotech

Drug Trial Radar · NCT06534502

Study of the Pharmacokinetics, Safety, and Tolerability of ZONISADE in Children 1 Month to 17 Years of Age With Partial-onset Seizures

A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Zonisamide Oral Suspension (100 mg/5 ml) to Determine a Dosing Regimen in Children 1 Month to 17 Years of Age With Partial-onset Seizures

Last checked: Nov 20, 2026Latest source record: Sep 15, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Not yet recruiting

Status

Not yet recruiting

Enrollment

40

Planned (sponsor's estimate)

Start

Sep 2026

Primary completion

Sep 2027

Study completion Sep 2027

Sponsor

Lead sponsor
Azurity PharmaceuticalsIndustry
Sponsor type
Industry
First posted
Aug 2, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 1 month, up to 17 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this research is to determine the optimal dose, safety and tolerability of zonisamide oral suspension in children ages 1 month to 17 years of age who have partial-onset (focal) seizures. The study consists of four periods: a Screening Period (about 14 days), a Titration Period (8 weeks), a Maintenance Period (4 weeks), and a Follow-Up Period (1 week).

Conditions

  • Seizures
  • Seizures, Focal
  • Seizure, Partial Onset
  • Seizure Disorder, Partial
  • Seizure, Partial
  • Epilepsies, Partial
  • Epilepsy

Interventions

  • Zonisamide Oral ProductDrug

    Zonisamide oral suspension

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Concentration of serum zonisamideTime frame: Up to 15 weeks

Locations

2 sites in 1 country. Site status is shown where the registry gives one.

  • Wake Forest University School of Medicine

    Winston-Salem, North Carolina

  • Le Bonheur Children's Hospital

    Memphis, Tennessee

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.